Док-1 Макс 100 мл сироп

Nazione: Kirghizistan

Lingua: russo

Fonte: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Principio attivo:

Парацетамол+гвайфенезин+фенилэфрин

Commercializzato da:

Marion Biotech Pvt. Ltd. (Marion Biotech Pvt. Ltd.)

Codice ATC:

N02BE51

INN (Nome Internazionale):

Acetaminophen+guaifenesin+phenylephrine

Dosaggio:

100 мл

Forma farmaceutica:

сироп

Confezione:

№1

Tipo di ricetta:

без рецепта

Prodotto da:

Marion Biotech Pvt. Ltd. (Индия)

Area terapeutica:

Противопростудное средство

Dettagli prodotto:

ПЖВЛС: нет

Data dell'autorizzazione:

2018-08-01

Scheda tecnica

llepnufi ra
.{enapra
oOecueqenraq
u
MUH
I4HCTPYKWfl
II O MEAI4III{HCKOMY
TIPUMEHEHIIIO
JIEK
CPENCTBA
AOK-I
MAKC CI{POI
TOPIOBOE HA3BAHIIE
.IIor-l
Marc
MEXAYHAPOAHOE
HETIATEHTOBAHHOE
HA3BAHIIE
Her
JIEKAPCTBEHHA'
@OPMA
Cnpon
:
COCTAB
KaxArre L0 rvrr
cnpona coAepr(ar:
Arcmueuue
seu4ecmsq:
flapaqerauon
E(D
500
rur
fsafi(penesras
E@
200 ur
@eHune$puHa
rr4Apoxnopua
E@
10 vrr
BcnouozamerbHbre
6et4ecmso:
[ponuneHfJrlrKoJrb,
xr,rArufi cop6uror
(uerpucrarusonauurrft),
6eH:oar
Harpr,rr,
caxapr{H
Harpvrfl,
cyKnapo3a,
MoHorr4Apar
luvroHnofi
KucJrorbr,
rnuuepr4H,
MeHToJr,
apoMarr43arop
nr4MoHHrrfi
,
xpacur:enb
KapaMeJrb,
BoAa
or{uqeHHar.
OTIIICAHI4E
Or cse'rro-Kopr4qHeBoro
Ao
KopaqHeBofo
rlBera
)r(HAKocrb,
c
xapaKTepHbrM
cnaAKHM
BKycoM.
OAPMAK O TEPATIE B T I,ITIE
CKA.g
TPYIITIA
AuarsreruKr4-aHTr4nuperr4Kr4
Apyrr4e.
AsumaAu. Ilapaqe'rauol
g
roN{6r4Haqur4
c
Apyrr4Mr4
ilpe[aparaMu
(ucrmovar
ucuxorenruru).
Koa ATX N02BE5l
@APMAKOJIOTIqE
CKIIE CBOIICTBA
(DapuaxoduHaMuKa:
[ox-L
Maxc
-
rou6usuponauHufi [peflapar,
Aeficreue
Koroporo cBfl3aHo
c KoMnoHeHTaMrz,
BXOA{rrIr,rMr.r
B
ero cocTaB.
llapaqer:arr,roJl
oKa3brBaer
6oreyronrrculee r4 )r(aponoHr.Dr(arcqee
4eficrnue,
Koropoe
o6rerqaer
cocrof,Hl4e
nr.rxopaAKr4
u 6ottu. fnafitfeHesHH
oKa3brBaer
MyKonr4Tr4qecKoe
4eficrnue,
crr.rMyJrprpyer
ceKperopH;Ie KJrerKr{
AbrxarenbHux
nyrefi
14
noMofaer
ynyq[r4Tr
bporxr.ralrurrfi
ceKper 14
MoKpory
nyrerra
yMeHbueHr.rs
e€
Br3Kocrlr.
fnafi(fenesran
noBbrrrraer
srf(fercrrannocrr
YTBEPXNAIO
MyKOUI4nr,IapHOrO
MeXaHI43Ma
Ant
yoTpaHeHr4r
HaKOnJreHHbrX
BbrAeJreHr4fi
r43 BepXHr{X
H HLTXHT4X
AbrxareJrbHbrx
nyrefi.
(Denune$puHa
rr4Apoxnopr.rA
oKa3brBaer
cBolo
AerrenbHocrb
Ba3oKoHcrpr4KTopa
BbrAeJrfltr
aApeHanr4H
r43 HepBHbrx oKoHqaHuir u
ot
nptMoro
eos6yx4euu.a
(peqerrropoB
a.qeHo3aHa>
KpoBeHocHLrx
cocyAoB.llocne
[epopanbHoro nplrMeHeHr,r.rr
cyxeHr4e
KpoBeHocHbrx cocyAoB
s
Hocoeoft
o6racru
rroMofaer
ycrpaHr4Tb
3aJloll(eHHocrb
uoca. B
TepaileBTr4r{ecKrax
Ao3ax
[penapar
He
Bbr3brBaer
KaKr4x-Jru6o
npe4uux
uo6oqnrrx
stp(perroB
npl4
crr4Mynf,
ur4a ueHTpanbuofi
ue